HND-02

N/A

Report date: 2025/09/28 16:28:00
NME

Base Information

Drug NameHND-02
Drug Alias NameHND-02
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionABL proto-oncogene 1 inhibitorsTyrosine-protein kinase BTK inhibitors
TargetsTyrosine-protein kinase BTKABL proto-oncogene 1
Therapy Area/IndicationsArthritis, RheumatoidLeukemia, Myelogenous, ChronicNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHunan Warrant Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHunan Warrant Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsArthritis, RheumatoidLeukemia, Myelogenous, Chronic
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A